Evidence map›Paper›PMID 35831356›Full record

ArticleScientific reports2022

Development of a screening algorithm for borderline personality disorder using electronic health records.

Chengxi Zang, Marianne Goodman, Zheng Zhu, Lulu Yang, Ziwei Yin, Zsuzsanna Tamas, Vikas Mohan Sharma, Fei Wang, Nan Shao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Chengxi ZangDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Marianne GoodmanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Zheng ZhuBoehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Ridgefield, CT, USA.
Lulu YangBoehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Ridgefield, CT, USA.
Ziwei YinBoehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Ridgefield, CT, USA.
Zsuzsanna TamasBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Vikas Mohan SharmaBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Fei WangDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. few2001@med.cornell.edu.
Nan ShaoBoehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Ridgefield, CT, USA. nanshao822@gmail.com.
Boehringer Ingelheim (United States) · USBoehringer Ingelheim (Germany) · DECornell University · USIcahn School of Medicine at Mount Sinai · USWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Borderline personality disorder (BoPD or BPD) is highly prevalent and characterized by reactive moods, impulsivity, behavioral dysregulation, and distorted self-image. Yet the BoPD diagnosis is underutilized and patients with BoPD are frequently misdiagnosed resulting in lost opportunities for appropriate treatment. Automated screening of electronic health records (EHRs) is one potential strategy to help identify possible BoPD patients who are otherwise undiagnosed. We present the development and analytical validation of a BoPD screening algorithm based on routinely collected and structured EHRs. This algorithm integrates rule-based selection and machine learning (ML) in a two-step framework by first selecting potential patients based on the presence of comorbidities and characteristics commonly associated with BoPD, and then predicting whether the patients most likely have BoPD. Leveraging a large-scale US-based de-identified EHR database and our clinical expert's rating of two random samples of patient EHRs, results show that our screening algorithm has a high consistency with our clinical expert's ratings, with area under the receiver operating characteristic (AUROC) 0.837 [95% confidence interval (CI) 0.778-0.892], positive predictive value 0.717 (95% CI 0.583-0.836), accuracy 0.820 (95% CI 0.768-0.873), sensitivity 0.541 (95% CI 0.417-0.667) and specificity 0.922 (95% CI 0.880-0.960). Our aim is, to provide an additional resource to facilitate clinical decision making and promote the development of digital medicine.

Indexed as

Borderline Personality DisorderElectronic Health RecordsAlgorithmsDatabases, FactualHumansMachine Learning

Identifiers

PMID35831356
PMCPMC9279396
OpenAlexW4285394749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.